Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and Anxiety.

Mehdi, Askar; Schweinsburg, Brian C; Zehgeer, Asima; Connor, Daniel F; Luber, Maxwell J; Coffey, Barbara J

Mehdi, Askar; Schweinsburg, Brian C; Zehgeer, Asima; Connor, Daniel F; Luber, Maxwell J; Coffey, Barbara J.

Afiliação

Mehdi A; 1 Division of Child and Adolescent Psychiatry, University of Connecticut Medical School , Farmington, Connecticut.
Schweinsburg BC; 1 Division of Child and Adolescent Psychiatry, University of Connecticut Medical School , Farmington, Connecticut.
Zehgeer A; 1 Division of Child and Adolescent Psychiatry, University of Connecticut Medical School , Farmington, Connecticut.
Connor DF; 1 Division of Child and Adolescent Psychiatry, University of Connecticut Medical School , Farmington, Connecticut.
Luber MJ; 2 Department of Psychiatry, Icahn School of Medicine at Mount Sinai , New York, New York.
Coffey BJ; 2 Department of Psychiatry, Icahn School of Medicine at Mount Sinai , New York, New York.

J Child Adolesc Psychopharmacol ; 26(10): 944-947, 2016 12.

Article em En | MEDLINE | ID: mdl-27992258

Assuntos

Transtornos de Ansiedade/terapia; Psicofarmacologia/métodos; Esquizofrenia/terapia; Adolescente; Fatores Etários; Criança; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Psicofarmacologia / Esquizofrenia Limite: Adolescent / Child / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Assunto da revista: PEDIATRIA / PSICOFARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google